AYTU BIOPHARMA INC (AYTUXXXX)
Institutional ownership reported to the SEC as of Q1 2023, across 10 quarters.
1
Reporting holders
$1
Reported value
0.0%
Held as options
-22
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Ronald Blue Trust, Inc. | $1 | 5,579 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 1 | $1 | 5,579 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 23 | $700.4K | 3,706,529 | 5 | 4 | 5 | 0.0% |
| Q3 2022 | 35 | $1.7M | 8,851,163 | 12 | 7 | 7 | 1.3% |
| Q2 2022 | 28 | $2.6M | 3,618,336 | 5 | 6 | 9 | 5.4% |
| Q1 2022 | 28 | $6.2M | 5,580,107 | 2 | 8 | 12 | 2.7% |
| Q4 2021 | 35 | $5.8M | 3,854,297 | 6 | 8 | 14 | 5.9% |
| Q3 2021 | 36 | $12.6M | 4,246,405 | 2 | 16 | 11 | 2.8% |
| Q2 2021 | 47 | $28.0M | 5,182,971 | 11 | 15 | 15 | 7.3% |
| Q1 2021 | 59 | $48.7M | 6,366,454 | 25 | 22 | 6 | 0.6% |
| Q4 2020 | 39 | $25.8M | 4,306,849 | 39 | 0 | 0 | 0.0% |